DRTS · Alpha Tau Medical Ltd. · Financials
Market Cap
$1.33B
Shares
92.48M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Net Income
-$42.63M
-34.3%
FY2025
Diluted EPS
-$0.53
-17.8%
FY2025
Operating Cash Flow
-$26.68M
-34.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| $32.07M | $27.02M | $26.42M | $20.89M | $11.45M | $7.54M | $6.64M | |
| $8.36M | $6.67M | $7.33M | $10.27M | $1.86M | $1.41M | $977K | |
| -$42.29M | -$36.04M | -$35.68M | -$32.14M | -$13.79M | -$9.24M | $8.01M | |
| $347K | $303K | $75K | — | — | — | — | |
| -$218K | $4.3M | $6.54M | -$1.61M | -$13.47M | — | — | |
| -$42.51M | -$31.74M | -$29.14M | -$33.74M | -$27.26M | -$8.72M | $8.32M | |
| $121K | $6000 | $16K | $20K | $7000 | $158K | -$146K | |
| -$42.63M | -$31.75M | -$29.16M | -$33.76M | -$27.27M | -$8.88M | -$8.37M | |
| — | — | — | — | — | — | -$97K | |
| -$42.63M | -$31.75M | -$29.16M | -$33.76M | -$27.27M | -$8.88M | — | |
| USD/shares | -$0.53 | -$0.45 | -$0.42 | -$0.53 | -$0.67 | -$0.22 | -$0.25 |
| USD/shares | -$0.53 | -$0.45 | -$0.42 | -$0.53 | -$0.67 | -$0.22 | -$0.25 |
| shares | 80.58M | 69.93M | 69.38M | 63.53M | 40.53M | 40.27M | 33.82M |
| shares | 80.58M | 69.93M | 69.38M | 63.53M | 40.53M | 40.27M | 33.82M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.